Identification of a Chemokinetic Inhibitor in Serum from Patients with Chronic Lymphocytic Leukaemia
- 1 February 1982
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 28 (2) , 122-131
- https://doi.org/10.1111/j.1600-0609.1982.tb00504.x
Abstract
The effects of serum from patients with chronic lymphocytic leukaemia (CCL) on normal polymorphonuclear leucocyte migration (PMN) were examined by means of the leading front technique, using a modified Boyden chamber. 18 randomly selected patients were studied. 13 patients had a reduced chemokinetic activity. The defective migration was explained by the finding in serum from these patients of cell‐directed inhibitory activity which was destroyed by heating (56°C, 30 min). The B‐lymphocytes as the origin of the inhibitory activity was suggested by the presence of a similar activity in supernatants from cultured tumour cells. 6 of the 18 patients had the combination of a defective chemokinetic activity and low levels of immunoglobulins. These 6 patients had an increased tendency towards infections.Keywords
This publication has 18 references indexed in Scilit:
- Neutrophil function in infection-prone children.Archives of Disease in Childhood, 1980
- The Influence of Serum on Random Migration and Chemotaxis of Polymorphonuclear Leucocytes: Methodological Evaluation using Sera from Infection‐prone Patients and NormalsScandinavian Journal of Immunology, 1980
- Biochemical Characteristics of Chronic Lymphocytic LeukaemiaScandinavian Journal of Haematology, 1978
- Serum-associated inhibition of leukotaxis in humans with cancerClinical Immunology and Immunopathology, 1978
- Leukotactic Dysfunction in SarcoidosisAnnals of Internal Medicine, 1976
- Two Distinct Chemotactic Factor Inactivators in Human SerumThe Journal of Immunology, 1975
- Products of Activated Lymphocytes: Leukocyte Inhibitory Factor (LIF) Distinct from Migration Inhibitory Factor (MIF)The Journal of Immunology, 1974
- Defective Regulation of Inflammatory Mediators in Hodgkin's DiseaseNew England Journal of Medicine, 1974
- Chemotactic Factor Inactivator in Normal Human SerumJournal of Clinical Investigation, 1973
- Infection and Immunity in Chronic Lymphocytic LeukemiaArchives of internal medicine (1960), 1960